NCT02415179View on ClinicalTrials.gov

Effect of Inhaled Mometasone/Formoterol Versus Inhaled Fluticasone/Salmeterol in Asthma Patients

NACompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

February 29, 2016

Study Completion Date

February 29, 2016

Conditions
Asthma
Interventions
DRUG

Inhaled Mometasone/formoterol

Inhaled Mometasone/formoterol (100/5 microgram) 2 puffs twice daily via metered dose inhaler for 6 weeks

DRUG

Inhaled Fluticasone/Salmeterol

Inhaled Fluticasone/Salmeterol (125/25 microgram) 2 puffs twice daily delivered by using metered dose inhaler for 6 weeks

Trial Locations (1)

Unknown

Faculty of Medicine, Ramathibodi Hospital, Bangkok

All Listed Sponsors
lead

Mahidol University

OTHER

NCT02415179 - Effect of Inhaled Mometasone/Formoterol Versus Inhaled Fluticasone/Salmeterol in Asthma Patients | Biotech Hunter | Biotech Hunter